Divi’s, JB Chemicals Power Nifty Pharma to Fresh Gains; Index Outshines Broader Market with 0.74% Jump
By Shishta Dutta | Updated at: Jun 13, 2025 10:24 AM IST
Mumbai, 12 June 2025: The Nifty Pharma index posted a strong 0.74% intraday rise, climbing to 22,221.30, as investor appetite returned to pharmaceutical stocks. The sectoral gauge outperformed the broader markets, with 14 out of 20 constituents closing higher, signalling renewed bullish sentiment in both large and mid-cap pharma names.
As of 2:26 PM IST on June 12, the Nifty Pharma index traded at 21,997.00, down 60.15 points or 0.27% from the previous close of 22,057.15. The index opened at 22,124.80 and touched an intraday high of 22,354.75 by 2:25 PM, before slipping to a low of 21,973.25. Despite the decline, Nifty Pharma remains well above its 52-week low of 19,121.10, though still below its 52-week high of 23,907.90, reflecting cautious sentiment in the sector.
Nifty Pharma Intraday Snapshot
| Metric | Value |
|---|---|
| Opening Level | 22,124.80 |
| Day’s High | 22,354.75 |
| Day’s Low | 22,106.30 |
| Previous Close | 22,057.15 |
| Last Traded Price | 22,221.30 |
| Absolute Change | +164.15 |
| Percentage Change | +0.74% |
| 52-Week High | 23,907.90 |
| 52-Week Low | 19,121.10 |
| 30-Day Gain | +4.52% |
| 1-Year Gain | +12.02% |
| Total Traded Value | ₹2,219.65 Cr |
| Total Traded Volume | 1.61 Cr shares |
Top Gainers in Nifty Pharma
| Stock | Price (₹) | Change (₹) | Change (%) | 30-Day Change (%) | 1-Year Change (%) |
|---|---|---|---|---|---|
| Divi’s Labs | 6,804.00 | +85.00 | +1.27% | +13.08% | +50.13% |
| JB Chemicals | 1,750.00 | +32.40 | +1.89% | +10.30% | -8.87% |
| Ajanta Pharma | 2,735.00 | +88.20 | +3.33% | +6.63% | +11.00% |
| Torrent Pharma | 3,257.00 | +51.20 | +1.60% | -0.99% | +12.44% |
| Dr. Reddy’s | 1,364.50 | +13.40 | +0.99% | +13.01% | -77.63% |
Stocks Approaching 52-Week Highs
- Divi’s Laboratories is currently just 0.85% below its 52-week high of ₹6,862.50.
- JB Chemicals is trading 13.8% lower than its yearly peak.
- Laurus Labs, which has surged 52.99% over the past year, is within 1% of its 52-week high.
Underperformers of the Day
| Change (%) | Near 52W High (%) | 30-Day Change (%) | |||
|---|---|---|---|---|---|
| Granules India | 530.40 | -5.80 | -1.08% | -26.44% | +16.53% |
| Abbott India | 31,510.00 | -125.00 | -0.40% | -2.14% | +5.22% |
| Cipla | 1,516.00 | -5.70 | -0.37% | -10.93% | +0.67% |
| Alkem Labs | 4,870.00 | -15.50 | -0.32% | -24.38% | -2.69% |
Sector Overview
Despite the Nifty 50 slipping 0.30%, the Nifty Pharma index demonstrated strength, lifted by defensive buying and positive outlooks on sector-specific growth. Gains in heavyweights like Divi’s Labs and JB Chemicals were backed by solid trading volumes, further underlining the sector’s relative resilience.
Market Outlook
With multiple pharma stocks nearing their 52-week highs and several recording double-digit returns over the past month, momentum appears to be on the sector’s side. Defensive positioning, stable export prospects, and robust global demand are expected to keep investor confidence intact in the short to medium term.
About the Nifty Pharma Index
The Nifty Pharma Index tracks 20 NSE-listed pharmaceutical firms, encompassing a wide range of large, mid, and small-cap drug manufacturers and exporters. It is considered a key benchmark for evaluating the health and performance of India’s pharmaceutical and healthcare sector.
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
